share_log

荃信生物-B:中國證監會受理本公司H股全流通計劃申請

QYUNS-B: ACCEPTANCE BY THE CSRC OF APPLICATION FOR THECOMPANY'S H SHARE FULL CIRCULATION PLAN

HKEX ·  Oct 28, 2024 16:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more